Trial · NCT03178643
Results by group42
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 42
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Incidence of Clinical Malaria Per Patient Year | Proguanil Oral Tablet | 0.04 | episodes/patient year | ||
| Incidence of Clinical Malaria Per Patient Year | Sulfadoxine/Pyrimethanine-Amodiaquine | 3.05 | episodes/patient year | ||
| Incidence of Clinical Malaria Per Patient Year | Dihydroartemisinin-Piperaquine (DP) | 1.36 | episodes/patient year | ||
| Number of Participants With Severe Anemia | Proguanil Oral Tablet | 8 | Participants | ||
| Number of Participants With Severe Anemia | Sulfadoxine/Pyrimethanine-Amodiaquine | 9 | Participants | ||
| Number of Participants With Severe Anemia | Dihydroartemisinin-Piperaquine (DP) | 4 | Participants | ||
| Number of Participants With Severe Malaria | Proguanil Oral Tablet | 0 | Participants | ||
| Number of Participants With Severe Malaria | Sulfadoxine/Pyrimethanine-Amodiaquine | 0 | Participants | ||
| Number of Participants With Severe Malaria | Dihydroartemisinin-Piperaquine (DP) | 0 | Participants | ||
| Number of Participants With Hospitalization for Malaria | Proguanil Oral Tablet | 3 | Participants | ||
| Number of Participants With Hospitalization for Malaria | Sulfadoxine/Pyrimethanine-Amodiaquine | 3 | Participants | ||
| Number of Participants With Hospitalization for Malaria | Dihydroartemisinin-Piperaquine (DP) | 3 | Participants | ||
| Number of Participants With Light Microscopy (LM)-Positive Malaria | Proguanil Oral Tablet | 17 | Participants | ||
| Number of Participants With Light Microscopy (LM)-Positive Malaria | Sulfadoxine/Pyrimethanine-Amodiaquine | 11 | Participants | ||
| Number of Participants With Light Microscopy (LM)-Positive Malaria | Dihydroartemisinin-Piperaquine (DP) | 19 | Participants | ||
| Number of Participants With Unconfirmed Malaria | Proguanil Oral Tablet | 42 | Participants | ||
| Number of Participants With Unconfirmed Malaria | Sulfadoxine/Pyrimethanine-Amodiaquine | 25 | Participants | ||
| Number of Participants With Unconfirmed Malaria | Dihydroartemisinin-Piperaquine (DP) | 40 | Participants | ||
| Number of Participants With Fatal Malaria | Proguanil Oral Tablet | 0 | Participants | ||
| Number of Participants With Fatal Malaria | Sulfadoxine/Pyrimethanine-Amodiaquine | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03178643/results